Publication not explained

This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.

If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.

Featured Image

Read the Original

This page is a summary of: Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies, Vascular Health and Risk Management, February 2011, Taylor & Francis,
DOI: 10.2147/vhrm.s16925.
You can read the full text:



The following have contributed to this page